Main Session: Managing the Continuum of Myeloid Malignancies (CML, MPN, MDS, and AML)

What are the indications of a germline predisposition in a patient with a known or suspected myeloid malignancy?

Jean Ridgeway, DNP, APN, NP-C, AOCN, and Andrew Artz, MD

Jean Ridgeway, DNP, APN, NP-C, AOCN, and Andrew Artz, MD, on managing myeloid malignancies.


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here